Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Norway
/
Pharmaceuticals & Biotech
Create a narrative
ArcticZymes Technologies
OB:AZT Community
1
Narratives
written by author
0
Comments
on narratives written by author
5
Fair Values set
on narratives written by author
Create a narrative
ArcticZymes Technologies
Popular
Undervalued
Overvalued
ArcticZymes Technologies
WA
Analyst Price Target
Consensus Narrative from 2 Analysts
Transition To Solution Provider Will Accelerate Market Penetration By Late 2025
Key Takeaways ArcticZymes is shifting from raw materials to solutions, aiming for revenue growth through closer customer interactions and market penetration by late 2025. New product launches and OEM agreements are set to boost revenue and competitive positioning, especially in cell and gene therapy markets.
View narrative
NOK 16.00
FV
18.1% overvalued
intrinsic discount
13.36%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
24 days ago
author updated this narrative
Your Valuation for
AZT
ArcticZymes Technologies
Your Fair Value
NOK
Current Price
NOK 18.90
30.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-25m
219m
2015
2018
2021
2024
2025
2027
2030
Revenue NOK 218.8m
Earnings NOK 15.3m
Advanced
Set as Fair Value